The possible association between the variations in the percentage of P2X7 in CD8+ T cells and chemoresistance, in patients with small initial tumor size (≤ 5 cm), could be a preliminarily indicator of chemoresistance and aid doctors during the decision-making when administering the first-line chemotherapy regimen. Here, P2RX7 is linked to neoplasm.